Home > Boards > US Listed > Biotechs > Aurinia Pharmaceuticals Inc (AUPH)

https://realmoney.thestreet.com/investing/stocks/my-top-stock-pick-for-2020-is-a-super-strong-finish

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
thesaud Member Profile
 
Followed By 7
Posts 2,561
Boards Moderated 0
Alias Born 01/25/12
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/19/2020 5:13:41 PM
Aurinia Announces AURORA Phase 3 Clinical Data for Voclosporin in Lupus Nephritis to be Presented at National Kidney Foundati... Business Wire - 3/18/2020 6:05:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/17/2020 5:06:09 PM
Aurinia Pharmaceuticals Establishes U.S. Commercial Operations Center in Rockville, Maryland Business Wire - 3/17/2020 6:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/16/2020 5:19:41 PM
Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the U.S. Food & Drug Administration for Voc... Business Wire - 3/16/2020 6:05:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/12/2020 4:06:08 PM
Aurinia Launches Resource Kit for People Living With Lupus Nephritis & Partners With National Kidney Foundation on Awareness ... Business Wire - 3/12/2020 7:00:00 AM
Annual Report (foreign Private Issuer) (40-f) Edgar (US Regulatory) - 3/5/2020 4:07:54 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/5/2020 4:02:58 PM
Aurinia Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights Business Wire - 3/5/2020 4:02:00 PM
Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results on March 5, 2020 Business Wire - 3/3/2020 6:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/25/2020 6:31:46 AM
Aurinia Appoints Max Colao as Chief Commercial Officer and Expands U.S. Commercial Leadership Team Business Wire - 2/25/2020 6:30:00 AM
Aurinia Pharmaceuticals to Present at the 9th Annual SVB Leerink Global Healthcare Conference Business Wire - 2/21/2020 4:05:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/14/2020 1:21:11 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 4:31:26 PM
Aurinia Closes US$191.7 Million Public Offering of Common Shares & Full Exercise of Underwriters’ Option to Purchase Additi... Business Wire - 12/12/2019 9:26:00 AM
Aurinia Prices US$166.7 Million Public Offering of Common Shares Business Wire - 12/9/2019 9:00:00 PM
Aurinia Announces Public Offering of Common Shares Business Wire - 12/9/2019 6:01:00 AM
Aurinia Announces Positive AURORA Phase 3 Trial Results Demonstrating Voclosporin Superiority Over Standard of Care in Lupus ... Business Wire - 12/4/2019 4:05:00 PM
Aurinia to Present Preclinical Voclosporin Data at 2020 Keystone Symposia Conference Business Wire - 12/3/2019 6:30:00 AM
Aurinia Reports Third Quarter 2019 Financial Results and Recent Operational Highlights Business Wire - 11/14/2019 4:02:00 PM
Aurinia Announces Updates to the Board of Directors Business Wire - 11/13/2019 4:05:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/7/2019 6:32:40 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist